The DOI matches its Crossref record.
Drug Delivery Systems
Abstract
Drug delivery technologies represent a vast and vital area of Research and Development. The demand for innovative drug delivery systems continues to grow, and this growth continues to drive new developments. Building on the foundation provided by the first edition, Drug Delivery Systems, Second Edition covers the latest developments in both
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Emerging applications of stimuli-responsive polymer materials
Stuart, M. A. C., Huck, W. T. S., Genzer, J., Müller, M., Ober, C., Stamm, M., Sukhorukov, G. B., Szleifer, I., Tsukruk, V. V., Urban, M., et al. (2010) · Nature Materials · doi:10.1038/nmat2614 · Cited by 5,707
A detailed examination of boronic acid–diol complexation
Springsteen, G., & Wang, B. (2002) · Tetrahedron · doi:10.1016/s0040-4020(02)00489-1 · Cited by 1,461
Physicochemical Foundations and Structural Design of Hydrogels in Medicine and Biology
Peppas, N. A., Huang, Y., Torres-Lugo, M., Ward, J. H., & Zhang, J. (2000) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.2.1.9 · Cited by 1,016
Chitosan: A Unique Polysaccharide for Drug Delivery
Felt, O., Buri, P., & Gurny, R. (1998) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049809089942 · Cited by 769
Rothbard, J. B., Garlington, S., Lin, Q., Kirschberg, T., Kreider, E., McGrane, P. L., Wender, P. A., & Khavari, P. A. (2000) · Nature Medicine · doi:10.1038/81359 · Cited by 632
Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
Merisko-Liversidge, E. M., & Liversidge, G. G. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310946 · Cited by 579
Critical factors in the release of drugs from sustained release hydrophilic matrices
Maderuelo, C., Zarzuelo, A., & Lanao, J. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.04.002 · Cited by 551
Aldawood, F. K., Andar, A., & Desai, S. (2021) · Polymers · doi:10.3390/polym13162815 · Cited by 499
Tyrrell, Z. L., Shen, Y., & Radosz, M. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2010.06.003 · Cited by 481
Dunne, M., Corrigan, O. I., & Ramtoola, Z. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00040-5 · Cited by 444
Halaouli, S., Asther, M., Sigoillot, J.-C., Hamdi, M., & Lomascolo, A. (2006) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2006.02866.x · Cited by 359
Revisiting structure-property relationship of pH-responsive polymers for drug delivery applications
Bazban-Shotorbani, S., Hasani-Sadrabadi, M. M., Karkhaneh, A., Serpooshan, V., Jacob, K. I., Moshaverinia, A., & Mahmoudi, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.021 · Cited by 342
Hydroxyapatite and Hydroxyapatite-Based Ceramics
Orlovskii, V. P., Komlev, V. S., & Barinov, S. M. (2002) · Inorganic Materials · doi:10.1023/a:1020585800572 · Cited by 312
Anticancer Polymeric Nanomedicines
Tong, R., & Cheng, J. (2007) · Polymer Reviews · doi:10.1080/15583720701455079 · Cited by 310
Polymers and Drug Delivery Systems
Vilar, G., Tulla-Puche, J., & Albericio, F. (2012) · Current Drug Delivery · doi:10.2174/156720112801323053 · Cited by 296
Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs
Dubowchik, G. M., & Walker, M. A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00018-2 · Cited by 277
Role of topical peptides in preventing or treating aged skin
Gorouhi, F., & Maibach, H. I. (2009) · International Journal of Cosmetic Science · doi:10.1111/j.1468-2494.2009.00490.x · Cited by 193
Novel Oral Drug Formulations: Their Potential in Modulating Adverse Effects
Florence, A. T., & Jani, P. U. (1994) · Drug Safety · doi:10.2165/00002018-199410030-00005 · Cited by 84
Avnir, Y., Turjeman, K., Tulchinsky, D., Sigal, A., Kizelsztein, P., Tzemach, D., Gabizon, A., & Barenholz, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025721 · Cited by 72
Metadata
- Authors
- Ranade, V. V., Hollinger, M. A., & Cannon, J. B.
- Venue
- CRC Press eBooks
- Publisher
- CRC Press
- Published
- 2003-08-26
- OpenAlex
- W3147438120
- Cited by
- 456
- References
- 0
- FWCI
- 3.82
- Type
- book
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.